Arsenic Trioxide in Treating Patients With Multiple Myeloma

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory stage II or stage III multiple myeloma.

Timeline

Start

2001-01

Primary completion

2005-01

Completion

2005-01

Drugs

Indications